Big Pharma spends billions more on executives and stockholders than on R&D(arstechnica.com)
400 points by PaulHoule | 180 comments
Ars Technica article on a Senate report finding major drug companies spend more on executive pay and shareholder payouts than on R&D, citing patent thickets.